SCHEDULE: Vanguard Group Reports 0% Stake in Guardant Health

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Guardant Health Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 4 to Schedule 13G for Guardant Health Inc. common stock.
• The filing reports 0% beneficial ownership of Guardant Health Inc. common stock by The Vanguard Group.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately.
• These subsidiaries and/or business divisions are stated to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities beneficially owned by such subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for Guardant Health, as the change in beneficial ownership to 0% by The Vanguard Group is due to an internal organizational realignment rather than a divestment of shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that this filing reflects an internal organizational change within The Vanguard Group rather than a strategic divestment from Guardant Health. Such realignments are common among large asset managers to optimize reporting structures, and the underlying investment strategies for these assets are stated to remain consistent.

Stakeholder Impact

• Shareholders: The direct impact on Guardant Health shareholders is minimal, as the underlying investment strategies for the shares previously held by Vanguard are expected to continue under different reporting entities.
• The Vanguard Group: This reflects a change in internal reporting structure for compliance purposes, aligning with SEC guidance on disaggregated reporting.

Key Dates

Recommendation

The filing indicates an internal organizational realignment by The Vanguard Group, resulting in their reported beneficial ownership of Guardant Health Inc. common stock dropping to 0%. This is a technical reporting change rather than a strategic divestment, as the underlying investment strategies are stated to continue under different Vanguard entities. Therefore, it does not fundamentally alter the investment thesis for Guardant Health, warranting a 'hold' recommendation based solely on this filing.

Keywords

Guardant Health, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Investment Management, Corporate Realignment